Photo of Robin Bogner

Robin Bogner

  • E-Mail
  • Phone
    • (860) 486-2136
  • Fax
    • (860) 486-2076
  • Office
    • School of Pharmacy
      Room 438
  • Mail
    • University of Connecticut
      Dept. of Pharmaceutical Sciences
      69 North Eagleville Road
      Storrs, CT 06269-3092

Professor of Pharmaceutics

Educational Background

  • B.S. Rutgers University, Pharmacy
  • M.S. University of Iowa, Pharmaceutics
  • Ph.D. Rutgers University, Pharmaceutics

Research Interests

  • Dissolution enhancement of drug solubility
  • Rapid screening of dissolution solid forms formulations
  • Predicting product quality performance variation due to process variation

Selected Publications

  • Greco, K. and Bogner, R.H. (2012) Solution-mediated Phase Transformation: Significance during Dissolution and Implications for Bioavailability, Journal of Pharmaceutical Sciences 101(9), 2996-3018.
  • Qian, K.K., Wurster, D.E., Bogner, R.H. (2012) Spontaneous Crystalline-to-Amorphous Phase Transformation of Organic or Medicinal Compounds in the Presence of Porous Media, Part 3: Effect of Moisture, Pharmaceutical Research 29(10), 2698-2709.
  • Qian, K. and Bogner, R.H. (2012) Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. Journal of Pharmaceutical Sciences 101, 444-463.
  • Murdande, S.B., Pikal, M.J., Shanker, R.M., Bogner, R.H. (2011) Solubility Advantage of Amorphous Pharmaceuticals: III. Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?, Journal of Pharmaceutical Sciences 100(10), 4349-4356.
  • Greco, K., McNamara, D.P., Bogner, R. (2011) Solution-Mediated Phase Transformation of Salts During Dissolution: Investigation Using Haloperidol as a Model Drug, Journal of Pharmaceutical Sciences 100(7), 2755-2768.
  • Murdande, S.B., Pikal, M.J., Shanker, R.M., Bogner, R.H. (2011) Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement, Pharmaceutical Development and Technology 16(3), 187-200.